Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02688296 · ClinicalTrials.gov registry record
Effectiveness Of The Fibulock Intramedullary Nail
A clinical trial, sponsored by Arthrex.
- Completed
- Registry status
- 34
- Enrollment target
NCT02688296 is a clinical trial that has completed, run by Arthrex. The registered enrollment target is 34 participants.
The verdict
NCT02688296 has completed, sponsored by Arthrex.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The objective of this post-market clinical study is to evaluate efficacy outcomes and complication rates in patients who have received the Fibulock™ Intramedullary Nail.
Interventions
- DEVICE Fibulock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-05-24 |
| Est. Completion | 2020-07-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02688296
The ClinicalTrials.gov registry entry for NCT02688296 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arthrex, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fibulock is the first listed.
NCT02688296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02688296 about?
NCT02688296 is a clinical study titled "Effectiveness Of The Fibulock Intramedullary Nail". The objective of this post-market clinical study is to evaluate efficacy outcomes and complication rates in patients who have received the Fibulock™ Intramedullary Nail.
What is the current status of trial NCT02688296?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2016-05-24. Estimated completion is 2020-07-09.
What interventions are being tested in trial NCT02688296?
The interventions under investigation include: Fibulock (DEVICE).
Who is sponsoring clinical trial NCT02688296?
This trial is sponsored by Arthrex, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.